On Sep 7, 2021 EnteroBiotix closed a Series A round and raised £15,500,000 from Kineticos Ventures, Scottish Enterprise, SIS Ventures, Thairm Bio, featuring lead investors Thairm Bio.

About the company: EnteroBiotix is located at United Kingdom, Europe.
“EnteroBiotix are a leading microbiome therapeutics company pioneering the
future of modern medicine by modulating the structure and function of the
gut microbiome. We’re on a mission to harness the microbiome to transform
the lives of patients”

Company website: http://www.enterobiotix.com